Cargando…
Metal complexes in cancer therapy – an update from drug design perspective
In the past, metal-based compounds were widely used in the treatment of disease conditions, but the lack of clear distinction between the therapeutic and toxic doses was a major challenge. With the discovery of cisplatin by Barnett Rosenberg in 1960, a milestone in the history of metal-based compoun...
Autores principales: | Ndagi, Umar, Mhlongo, Ndumiso, Soliman, Mahmoud E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344412/ https://www.ncbi.nlm.nih.gov/pubmed/28424538 http://dx.doi.org/10.2147/DDDT.S119488 |
Ejemplares similares
-
Impact of Drug Repurposing on SARS-Cov-2 Main Protease
por: Ndagi, Umar, et al.
Publicado: (2023) -
Antibiotic resistance: bioinformatics-based understanding as a functional strategy for drug design
por: Ndagi, Umar, et al.
Publicado: (2020) -
An analogue of a kinase inhibitor exhibits subjective characteristics that contribute to its inhibitory activities as a potential anti-cancer candidate: insights through computational biomolecular modelling of UM-164 binding with lyn protein
por: Ndagi, Umar, et al.
Publicado: (2019) -
In Silico Drug Repurposing Approach: Investigation of Mycobacterium tuberculosis FadD32 Targeted by FDA-Approved Drugs
por: Ngidi, Nolwazi Thobeka Portia, et al.
Publicado: (2022) -
Drug Discovery for Mycobacterium tuberculosis Using Structure-Based Computer-Aided Drug Design Approach
por: Ejalonibu, Murtala A., et al.
Publicado: (2021)